WebAug 12, 2024 · Cytarabine is a medication used in the management and treatment of leukemias and lymphomas. It belongs to the antimetabolic group of medications. ... DNA replication and repair also halts due to the inhibition of DNA polymerase by cytarabine. This drug must act for a time equivalent to one cell cycle to effectively inhibit the replication of ... WebAlthough the mechanism of action is not completely understood, it appears that cytarabine acts through the inhibition of DNA polymerase. A limited, but significant, incorporation of …
Cytarabine: Uses, Interactions, Mechanism of Action
WebCytarabine is an effective antimetabolite in treating leukemia. Like other pyrimidine antimetabolites, cytarabine must be “activated” by initially transforming into the … WebA: to aid endocytosis. B: to make proteins from amino acids. C: to synthsise ATP. D: to make secretory products. D. What is the name given to the structures which penetrate … incidence of occurrence
Chemotherapeutic agents - Knowledge @ AMBOSS
WebJun 3, 2024 · DESCRIPTION: Cytarabine Injection, an antineoplastic, is a sterile solution of cytarabine for intravenous, intrathecal or subcutaneous administration. Each mL contains 100 mg cytarabine USP, in 2 g/20 mL (100 ... CLINICAL PHARMACOLOGY: Cell Culture Studies - Cytarabine is cytotoxic to a wide variety of proliferating mammalian cells in … WebMar 3, 2024 · Cell Culture Studies: Cytarabine is cytotoxic to a wide variety of proliferating mammalian cells in culture. It exhibits cell phase specificity, primarily killing cells undergoing DNA synthesis (S-phase) and under certain conditions blocking the progression of cells from the G 1 phase to the S-phase. Although the mechanism of action is not completely … WebDec 9, 2024 · Expected Reactions - Because cytarabine is a bone marrow suppressant, anemia, leukopenia, thrombocytopenia, megaloblastosis and reduced reticulocytes can be expected as a result of administration ... OVERDOSAGE There is no antidote for overdosage of Cytarabine Injection. inconsistency\\u0027s ad